| Characterization of the in vitro atropisomeric interconversion rates of an endothelin A antagonist by enantioselective liquid chromatography. | |
| | |
MedLine Citation:
|
PMID: 16007983 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Substituted biphenyl I (BMS-207940), a selective antagonist of the endothelin A (ETA) receptor, has been proposed for the treatment of congestive heart failure. The structure of I possesses a stereogenic axis due to the hindered rotation about the biphenyl bond in the presence of its large ortho-substituents. As a result, I exhibits atropisomerism in which two nonplanar, axially enantiomers exist, which will be generically referred to as isomers A and B. Within the pharmaceutical industry, both from a scientific and regulatory point of view, characterization of enantiomeric drugs has become an important step in the development process. To investigate the configurational stability of I atropisomers, normal phase enantiomeric LC with tandem UV and laser polarimetric detection was used under pseudo-physiological conditions: first in a simple aqueous medium at 37 degrees C, and then in human serum at 37 degrees C. Kinetic studies indicated that the half-life of I enantiomerization in an aqueous medium at 37 degrees C was ca. 15 h. Enantiomerization of I atropisomers was greatly accelerated in the presence of human serum and human serum albumin, and the rate of enantiomerization depended on the concentration of I. The sera-concentration-dependent enantiomerization behavior of I strongly suggests a restricted site-specific substrate/I interaction mechanism. It was therefore demonstrated that atropisomeric interconversion studies for the compound studied required consideration of temperature, presence of plasma proteins, and drug concentration to account for the kinetic data. |
| | |
Authors:
|
Yueer Shi; Ming-Hsing Huang; John E Macor; David Emlyn Hughes |
Related Documents
:
|
6813663 - Phenytoin elimination after intoxication during long-term treatment. 17289313 - Adsorption of drugs onto a ph responsive poly(n,n-dimethyl aminoethyl methacrylate) gra... 8358693 - Calgary's needle exchange program: profile of injection drug users. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of chromatography. A Volume: 1078 ISSN: 0021-9673 ISO Abbreviation: J Chromatogr A Publication Date: 2005 Jun |
Date Detail:
|
Created Date: 2005-07-12 Completed Date: 2005-09-08 Revised Date: 2009-01-15 |
Medline Journal Info:
|
Nlm Unique ID: 9318488 Medline TA: J Chromatogr A Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 67-73 Citation Subset: IM |
Affiliation:
|
Bristol-Myers Squibb Company, Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543-4000, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biphenyl Compounds
/
chemistry*,
isolation & purification Blood Proteins Chromatography, High Pressure Liquid / methods* Half-Life Humans Kinetics Lasers Molecular Conformation Oxazoles / blood, chemistry*, isolation & purification Receptor, Endothelin A / antagonists & inhibitors* Spectrophotometry, Ultraviolet Stereoisomerism Sulfonamides / blood, chemistry*, isolation & purification |
| Chemical | |
Reg. No./Substance:
|
0/Biphenyl Compounds; 0/Blood Proteins; 0/N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,3,3-trimethylbutanamide; 0/Oxazoles; 0/Receptor, Endothelin A; 0/Sulfonamides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Investigation of the extraction behavior of the main monoglutamate folates from spinach by liquid ch...
Next Document: Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing.